New Zealand - GSK
WEBNew Zealand. At GSK, we unite science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines investing in four core therapeutic areas: infectious …
Helping healthcare professionals to support New Zealand patients - GSKpro
WEBGet access to free patient resources, exclusive webinars on the topics that matter to you and updates on the latest in our leading therapy areas, and more. REGISTER FOR ACCESS. Adverse events involving GlaxoSmithKline products should be reported to GSK Medical Information on 0800 808 500.
Summary of decision: shingles vaccine for some ... - Pharmac
WEBApr 12, 2024 · Pharmac is widening access to the shingles vaccine for some immunocompromised people through a multiproduct agreement with GlaxoSmithKline New Zealand (GSK).
Worldwide - GSK
WEBOur contact directory for GSK operations around the world. Privacy questions: Should you have any questions or concerns regarding privacy at GSK, please reach out to us using the contact information specific to your location, provided below. Africa & …
GlaxoSmithKline in New Zealand - ICH GCP
WEBWe are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, …
Summary of decision: single inhaler triple-therapy for COPD
WEBPharmac is funding a single inhaler triple-therapy for chronic obstructive pulmonary disease (COPD) through a multiproduct agreement with GlaxoSmithKline New Zealand (GSK).
Pharmac inks deal with GlaxoSmithKline for new cancer, HIV and …
WEBApr 12, 2024 · About 30,000 New Zealanders with ovarian cancer, lung disease, HIV and other conditions will now get access to new medicines under a deal between Pharmac and pharmaceutical giant GlaxoSmithKline.
More than 30,000 people to benefit under Pharmac proposal
WEBThe treatments in this proposal, with the supplier GlaxoSmithKline New Zealand (GSK), include: funding niraparib (branded as Zejula) for three types of gynaecological cancers from 1 May 2024.
GLAXOSMITHKLINE NZ LIMITED Company Profile | Auckland, AUCKLAND, New ...
WEBFind company research, competitor information, contact details & financial data for GLAXOSMITHKLINE NZ LIMITED of Auckland, AUCKLAND. Get the latest business insights from Dun & Bradstreet.
Hello from Haleon - Haleon HealthPartner
WEBWe recently demerged from GSK Plc (formerly GlaxoSmithKline Plc) and became Haleon, a company single-mindedly focused on delivering better everyday health with humanity.
Skip to content